LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 150

Suchoptionen

  1. Artikel ; Online: COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases.

    Reemann, Lea / Kneidinger, Nikolaus / Sczepanski, Bernd / Koczulla, Andreas Rembert

    Viruses

    2024  Band 16, Heft 5

    Abstract: Due to immunosuppression, transplant recipients are at higher risk of infections with SARS-CoV-2 and worse clinical outcomes than immunocompetent hosts. Furthermore, lung transplant patients represent a special group among solid organ recipients, since ... ...

    Abstract Due to immunosuppression, transplant recipients are at higher risk of infections with SARS-CoV-2 and worse clinical outcomes than immunocompetent hosts. Furthermore, lung transplant patients represent a special group among solid organ recipients, since pneumonia is the main manifestation of COVID-19. However, data on the course of disease and the changes in morbidity and mortality during the course of the pandemic are limited. In our pulmonary rehabilitation clinic, we treat patients shortly after lung transplant as well as long-term transplant patients. Over the last almost 4 years of pandemic, we witnessed several COVID-19 infections in lung transplant patients in our clinic as well as patients who acquired an infection beforehand. In this paper, we aim at retrospectively describing a series of recent COVID-19 cases in our clinic, looking at the clinical course of disease and outcomes in lung transplant patients.
    Mesh-Begriff(e) Humans ; COVID-19/epidemiology ; Lung Transplantation/adverse effects ; Middle Aged ; Male ; Transplant Recipients ; Female ; Retrospective Studies ; SARS-CoV-2 ; Aged ; Adult ; Immunocompromised Host
    Sprache Englisch
    Erscheinungsdatum 2024-04-29
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Case Reports
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v16050709
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Reply to "Improvements in asthma control and quality of life with benralizumab are unrelated to baseline bronchodilator response".

    Milger, Katrin / Mümmler, Carlo / Kneidinger, Nikolaus

    The journal of allergy and clinical immunology. In practice

    2022  Band 10, Heft 12, Seite(n) 3342–3343

    Sprache Englisch
    Erscheinungsdatum 2022-12-08
    Erscheinungsland United States
    Dokumenttyp Letter
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2022.08.028
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres.

    Gottlieb, Jens / Kolditz, Martin / Gade, Nils / Welte, Tobias / Kneidinger, Nikolaus

    The European respiratory journal

    2022  Band 60, Heft 1

    Mesh-Begriff(e) Antibodies, Monoclonal/therapeutic use ; COVID-19/therapy ; Humans ; Lung Transplantation ; Retrospective Studies
    Chemische Substanzen Antibodies, Monoclonal
    Sprache Englisch
    Erscheinungsdatum 2022-07-21
    Erscheinungsland England
    Dokumenttyp Letter ; Multicenter Study
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00124-2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Einsatz antifibrotischer Medikamente bei interstitiellen Lungenerkrankungen.

    Kreutz, Claus-Peter / Gesierich, Wolfgang / Behr, Jürgen / Kneidinger, Nikolaus

    Deutsche medizinische Wochenschrift (1946)

    2022  Band 147, Heft 21, Seite(n) 1383–1390

    Abstract: The interstitial lung diseases ILDs are a heterogeneous group of diseases that often lead to progressive fibrosis of the lungs with corresponding functional impairment. With nintedanib, a tyrosinkinase inhibitor and angiokinase inhibitor, as well as ... ...

    Titelübersetzung Use of antifibrotic drugs in interstitial lung disease.
    Abstract The interstitial lung diseases ILDs are a heterogeneous group of diseases that often lead to progressive fibrosis of the lungs with corresponding functional impairment. With nintedanib, a tyrosinkinase inhibitor and angiokinase inhibitor, as well as pirfenidone, which unfolds its effect among other things by inhibiting the transforming growth factor β, there are currently 2 approved antifibrotic drugs. In the rapidly progressing idiopathic pulmonary fibrosis IPF, the antifibrotic drugs nintedanib and pirfenidone have been established and approved in therapy for several years. The initiation of antifibrotic therapy should be carried out early after diagnosis by multidisciplinary discussion (MDD). In systemic scleroderma with lung involvement nintedanib should be used in the case of relevant fibrosis in addition to immunosuppressive therapy. Recently, nintedanib has also become a new option for the treatment of progressive fibrosing ILDs (PF-ILDs). This describes the course of various disease entities such as connective tissue disease associated ILDs (CTD-ILDs), fibrosing hypersensitivity pneumonitis or fibrosing courses of non-IPF idiopathic interstitial pneumonitis (non-IPF IIPs) that have a corresponding fibrose-related worsening of respiratory symptoms, a deterioration of lung-functioning parameters or a disease progression in CT. Although pirfenidone also shows positive signals for this group of patients in some selected studies, its use in PF-ILD is not yet recommended. In particular, gastrointestinal side effects can occur under therapy with antifibrotic drugs and require a long-term close interdisciplinary connection of patients.
    Mesh-Begriff(e) Humans ; Disease Progression ; Fibrosis ; Idiopathic Pulmonary Fibrosis/drug therapy ; Idiopathic Pulmonary Fibrosis/metabolism ; Lung ; Lung Diseases, Interstitial/drug therapy ; Transforming Growth Factor beta/antagonists & inhibitors
    Chemische Substanzen Transforming Growth Factor beta
    Sprache Deutsch
    Erscheinungsdatum 2022-10-24
    Erscheinungsland Germany
    Dokumenttyp English Abstract ; Journal Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-1825-4967
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Konferenzbeitrag: Impact of illness and treatment on lung transplant candidates: A mixed methods study

    Griesbeck, Tom / Bausewein, Claudia / Neurohr, Claus / Kneidinger, Nikolaus / Schunk, Michaela

    2023  , Seite(n) 23dkvf411

    Veranstaltung/Kongress 22. Deutscher Kongress für Versorgungsforschung (DKVF); Berlin; Deutsches Netzwerk Versorgungsforschung; 2023
    Schlagwörter Medizin, Gesundheit
    Erscheinungsdatum 2023-10-02
    Verlag German Medical Science GMS Publishing House; Düsseldorf
    Dokumenttyp Konferenzbeitrag
    DOI 10.3205/23dkvf411
    Datenquelle German Medical Science

    Zusatzmaterialien

    Kategorien

  6. Konferenzbeitrag: Versorgungsgeschehen und palliativmedizinische Versorgungsbedarfe bei gelisteten Patienten und Patientinnen für eine Lungentransplantation – eine retrospektive Datenanalyse

    Huber, Simone / Bausewein, Claudia / Neurohr, Claus / Kneidinger, Nikolaus / Schunk, Michaela

    2023  , Seite(n) 23dkvf357

    Veranstaltung/Kongress 22. Deutscher Kongress für Versorgungsforschung (DKVF); Berlin; Deutsches Netzwerk Versorgungsforschung; 2023
    Schlagwörter Medizin, Gesundheit
    Erscheinungsdatum 2023-10-02
    Verlag German Medical Science GMS Publishing House; Düsseldorf
    Dokumenttyp Konferenzbeitrag
    DOI 10.3205/23dkvf357
    Datenquelle German Medical Science

    Zusatzmaterialien

    Kategorien

  7. Buch ; Online ; Dissertation / Habilitation: Die Auswirkungen des Tacrolimusspiegels und dessen Schwankung nach Lungentransplantation auf das Überleben der Patienten

    Klaubert, Niklas [Verfasser] / Kneidinger, Nikolaus [Akademischer Betreuer]

    2022  

    Verfasserangabe Niklas Klaubert ; Betreuer: Nikolaus Kneidinger
    Schlagwörter Medizin, Gesundheit ; Medicine, Health
    Thema/Rubrik (Code) sg610
    Sprache Deutsch
    Verlag Universitätsbibliothek der Ludwig-Maximilians-Universität
    Erscheinungsort München
    Dokumenttyp Buch ; Online ; Dissertation / Habilitation
    Datenquelle Digitale Dissertationen im Internet

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Tracheal stenosis in prolonged mechanically ventilated patients: prevalence, risk factors, and bronchoscopic management.

    Ghiani, Alessandro / Tsitouras, Konstantinos / Paderewska, Joanna / Munker, Dieter / Walcher, Swenja / Neurohr, Claus / Kneidinger, Nikolaus

    BMC pulmonary medicine

    2022  Band 22, Heft 1, Seite(n) 24

    Abstract: Background: Various complications may arise from prolonged mechanical ventilation, but the risk of tracheal stenosis occurring late after translaryngeal intubation or tracheostomy is less common. This study aimed to determine the prevalence, type, risk ... ...

    Abstract Background: Various complications may arise from prolonged mechanical ventilation, but the risk of tracheal stenosis occurring late after translaryngeal intubation or tracheostomy is less common. This study aimed to determine the prevalence, type, risk factors, and management of tracheal stenoses in mechanically ventilated tracheotomized patients deemed ready for decannulation following prolonged weaning.
    Methods: A retrospective observational study on 357 prolonged mechanically ventilated, tracheotomized patients admitted to a specialized weaning center over seven years. Flexible bronchoscopy was used to discern the type, level, and severity of tracheal stenosis in each case. We described the management of these stenoses and used a binary logistic regression analysis to determine independent risk factors for stenosis development.
    Results: On admission, 272 patients (76%) had percutaneous tracheostomies, and 114 patients (32%) presented mild to moderate tracheal stenosis following weaning completion, with a median tracheal cross-section reduction of 40% (IQR 25-50). The majority of stenoses (88%) were located in the upper tracheal region, most commonly resulting from localized granulation tissue formation at the site of the internal stoma (96%). The logistic regression analysis determined that obesity (OR 2.16 [95%CI 1.29-3.63], P < 0.01), presence of a percutaneous tracheostomy (2.02 [1.12-3.66], P = 0.020), and cricothyrotomy status (5.35 [1.96-14.6], P < 0.01) were independently related to stenoses. Interventional bronchoscopy with Nd:YAG photocoagulation was a highly effective first-line treatment, with only three patients (2.6%) ultimately referred to tracheal surgery.
    Conclusions: Tracheal stenosis is commonly observed among prolonged ventilated patients with tracheostomies, characterized by localized hypergranulation and mild to moderate airway obstruction, with interventional bronchoscopy providing satisfactory results.
    Mesh-Begriff(e) Aged ; Bronchoscopy ; Female ; Germany/epidemiology ; Humans ; Male ; Middle Aged ; Prevalence ; Respiration, Artificial/adverse effects ; Retrospective Studies ; Risk Factors ; Tracheal Stenosis/epidemiology ; Ventilator Weaning
    Sprache Englisch
    Erscheinungsdatum 2022-01-06
    Erscheinungsland England
    Dokumenttyp Journal Article ; Observational Study
    ZDB-ID 2059871-3
    ISSN 1471-2466 ; 1471-2466
    ISSN (online) 1471-2466
    ISSN 1471-2466
    DOI 10.1186/s12890-022-01821-6
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Mechanical power normalized to lung-thorax compliance indicates weaning readiness in prolonged ventilated patients.

    Ghiani, Alessandro / Paderewska, Joanna / Walcher, Swenja / Tsitouras, Konstantinos / Neurohr, Claus / Kneidinger, Nikolaus

    Scientific reports

    2022  Band 12, Heft 1, Seite(n) 6

    Abstract: Since critical respiratory muscle workload is a significant determinant of weaning failure, applied mechanical power (MP) during artificial ventilation may serve for readiness testing before proceeding on a spontaneous breathing trial (SBT). Secondary ... ...

    Abstract Since critical respiratory muscle workload is a significant determinant of weaning failure, applied mechanical power (MP) during artificial ventilation may serve for readiness testing before proceeding on a spontaneous breathing trial (SBT). Secondary analysis of a prospective, observational study in 130 prolonged ventilated, tracheotomized patients. Calculated MP's predictive SBT outcome performance was determined using the area under receiver operating characteristic curve (AUROC), measures derived from k-fold cross-validation (likelihood ratios, Matthew's correlation coefficient [MCC]), and a multivariable binary logistic regression model. Thirty (23.1%) patients failed the SBT, with absolute MP presenting poor discriminatory ability (MCC 0.26; AUROC 0.68, 95%CI [0.59‒0.75], p = 0.002), considerably improved when normalized to lung-thorax compliance (LTC
    Mesh-Begriff(e) Aged ; Female ; Humans ; Lung/physiopathology ; Lung Compliance ; Male ; Middle Aged ; Prospective Studies ; ROC Curve ; Respiration ; Thorax/physiopathology ; Tracheostomy ; Ventilator Weaning
    Sprache Englisch
    Erscheinungsdatum 2022-01-07
    Erscheinungsland England
    Dokumenttyp Journal Article ; Observational Study
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-03960-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities.

    Barnikel, Michaela / Kneidinger, Nikolaus / Arnold, Paola / Waelde, Andrea / Behr, Jürgen / Milger, Katrin

    Journal of clinical medicine

    2022  Band 11, Heft 4

    Abstract: Riociguat is licensed for the therapy of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to investigate whether age and comorbidities influence its tolerability and efficacy. Retrospectively, we analyzed data of tolerability, ... ...

    Abstract Riociguat is licensed for the therapy of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to investigate whether age and comorbidities influence its tolerability and efficacy. Retrospectively, we analyzed data of tolerability, non-invasive, and invasive efficacy at baseline and follow up (FU) of all patients with CTEPH treated with riociguat at the Department of Internal Medicine V, University of Munich (
    Sprache Englisch
    Erscheinungsdatum 2022-02-18
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11041084
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang